BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9749890)

  • 1. Recurrent abortion and moderate or strong antiphospholipid antibody production.
    Ogasawara M; Sasa H; Katano K; Aoyama T; Aoki K; Suzumori K
    Int J Gynaecol Obstet; 1998 Aug; 62(2):183-8. PubMed ID: 9749890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiphospholipid antibody syndrome in adverse pregnancy].
    Aoki K
    Rinsho Byori; 2000 Apr; 48(4):323-7. PubMed ID: 10810877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study.
    Sugiura-Ogasawara M; Ozaki Y; Nakanishi T; Sato T; Suzumori N; Kumagai K
    Am J Reprod Immunol; 2008 Mar; 59(3):235-41. PubMed ID: 18275516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific antiphospholipid antibodies as a predictive variable in patients with recurrent pregnancy loss.
    Aoki K; Hayashi Y; Hirao Y; Yagami Y
    Am J Reprod Immunol; 1993 Mar; 29(2):82-7. PubMed ID: 8329109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of anti-GM3 antibodies in recurrent pregnancy loss with elevated level of antiphospholipid antibodies.
    Ozaki Y; Aoki K; Aoyama T; Kunimatsu M
    Am J Reprod Immunol; 1995 Mar; 33(3):234-42. PubMed ID: 7546240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera.
    Katano K; Aoki K; Ogasawara M; Sasa H; Hayashi Y; Kawamura M; Yagami Y
    Lupus; 1995 Aug; 4(4):304-8. PubMed ID: 8528228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
    Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
    Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of clinically significant tests for antiphospholipid antibodies and cutoff levels for obstetric antiphospholipid syndrome.
    Kitaori T; Sugiura-Ogasawara M; Oku K; Papisch W; Ebara T; Ozaki Y; Katano K; Atsumi T
    Lupus; 2015 Dec; 24(14):1505-19. PubMed ID: 26162683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
    Malinowski A; Dyński MA; Maciołek-Blewniewska G; Głowacka E; Pawłowski T; Babula G
    Ginekol Pol; 2003 Oct; 74(10):1213-22. PubMed ID: 14669420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiphospholipid antibodies in women with habitual abortions. Treatment with prednisone and acetylsalicylic acid during pregnancy].
    Marco P; Lucas J; Alonso A; Pérez Vázquez J; Fernández P; Victoria C; García MC; Calatayud R
    Sangre (Barc); 1995 Oct; 40(5):389-92. PubMed ID: 8553173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study on pregnancy risk of antiphospholipid antibodies in association with systemic lupus erythematosus.
    Ogasawara M; Aoki K; Hayashi Y
    J Reprod Immunol; 1995 Feb; 28(2):159-64. PubMed ID: 7769581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study.
    Song Y; Wang HY; Qiao J; Liu P; Chi HB
    Chin Med J (Engl); 2017 Feb; 130(3):267-272. PubMed ID: 28139508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss.
    Clark CA; Spitzer KA; Crowther MA; Nadler JN; Laskin MD; Waks JA; Laskin CA
    J Rheumatol; 2007 May; 34(5):992-6. PubMed ID: 17407219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of antiphospholipid antibodies and antiphospholipid syndrome in women with recurrent miscarriages].
    Rajewski M; Skrzypczak J
    Ginekol Pol; 2011 Jan; 82(1):32-8. PubMed ID: 21473054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibodies: biological basis and prospects for treatment.
    Chamley LW
    J Reprod Immunol; 2002; 57(1-2):185-202. PubMed ID: 12385842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.